Search results
TMI, But This Buffing Bar Gave Me a Baby-Soft Butt After One Shower
STYLECASTER via Yahoo News· 3 hours agoIt reminds me a lot of the body scrubs I’d get at the Korean spa, but more gentle, and you can be...
Insider Sale at Xencor Inc (XNCR): EVP, Chief Development Officer Nancy Valente Sells Shares
GuruFocus.com via Yahoo Finance· 5 hours agoThe company uses its proprietary XmAb technology platform to create next-generation antibody...
Psst: That 10-Step Skincare Routine Might Be Hurting Your Face
The Wall Street Journal· 7 hours agoRetinol and retinoids are the most name-checked p.m. products for a reason: They have the best, most...
AMO Pharma to conduct Phase III trial of DM1 treatment
Clinical Trials Arena via Yahoo Finance· 18 hours agoThis decision follows a meeting with the US Food and Drug Administration (FDA), where the design and...
Puma Biotechnology, Inc. (NASDAQ:PBYI) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 11 hours agoPuma Biotechnology, Inc. (NASDAQ:PBYI) Q1 2024 Earnings Call Transcript May 2, 2024 Puma...
SSR MINING SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of...
WDTN-TV 2 Dayton· 1 hour agoClaimsFiler, a FREE shareholder information service, reminds investors that they have until May 17, 2024 to file lead plaintiff applications in a securities class action lawsuit against SSR ...
GLP-1R agonists clinical trial design must be improved to ease concerns
BioPharma-Reporter· 2 days agoThe efficacy of these medicines in type 2 diabetes and obesity patients has been proven to be...
Glecirasib Shows Promising Efficacy in KRAS-Mutated NSCLC
MedPage Today· 3 days agoTrend towards better response rate, PFS compared with approved KRAS inhibitors
Earnings call: Cerus Corporation sees growth with INTERCEPT RBCs trial success
Investing.com· 23 hours agoThe trial achieved its primary efficacy endpoint, demonstrating non-inferiority to conventional...
Cardiff Oncology, Inc. (NASDAQ:CRDF) Q1 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 13 hours agoCardiff Oncology, Inc. (NASDAQ:CRDF) Q1 2023 Earnings Call Transcript May 3, 2024 Cardiff Oncology,...